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Mediation of sperm-egg fusion: evidence that mouse egg a$, 
integrin is the receptor for sperm fetiiilinP 
Hui Chen and Nicole S Sampson 
, 
Introduction: A key step leading to fertilization is the binding of sperm to the 
egg plasma membrane. When a mammalian sperm reaches the egg plasm<3 
membrane, fertilinp, an extracellular sperm membrane protein, is believed to 
bind to an egg plasma membrane receptor triggering fusion. We set out to 
identify the fertilinp binding partner on the egg plasma membrane. 
Results: We synthesized an 1251-labeled peptide with the consensus 
Asp-Glu-Cys-Asp (DECD) sequence of fertilinfi’s disintegrin domain. This 
peptide contains a benzophenone photoaffinity probe and inhibits sperm-egg 
fusion. Upon photoactivation in the presence of whole mouse eggs, a sing e 
polypeptide was covalently labeled. This polypeptide has been identified by 
immunoprecipitation as an cx6 integrin complexed with p, integrin. 
Conclusions: Our experiments establish that small peptides containing the 
consensus DECD sequence of sperm fertilinp bind specifically to an a&, 
integrin receptor on the egg membrane. We conclude that fertilinp binds 
directly to the a&, integrin on the egg surface and this partnership mediates 
sperm-egg fusion. 
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Introduction 
Fertilization of a mammalian egg is a multistage process 
involving cell-matrix and cell-cell interactions that cul- 
minates in membrane fusion. First, sperm hydrolyze 
hyaluronic acid in the cumulus layer in order to pene- 
trate it and reach the zona pellucida, a glycoprotein 
matrix surrounding the egg. Upon sperm binding to the 
zona pellucida, the acrosome reaction is initiated, creat- 
ing a passage through the zona pellucida to the egg 
plasma membrane. In the final stages of fertilization. 
sperm bind and fuse with the egg plasma membrane. 
Although much progress has been made in characterizing 
the sperm-egg zona pellucida interactions, the molecular 
players required for sperm binding and fusion with the 
plasma membrane have not all been identified. In addi- 
tion, little is known about the signals that initiate embry- 
onic development or the cortical granule reaction that 
blocks polyspermic fertilization. 
.4 major breakthrough in understanding the molecular 
basis for sperm binding and fusion to the plasma mem- 
brane occurred with the discovery of fertilin. Fertilin is a 
membrane-bound protein that has been isolated from 
guinea pig [l] and cow [Z] as a complex of fertilina and 
fercilinp subunits. Fertilin is present on the equatorial 
region of the mouse sperm head where initiation of fusion 
events occurs [3]. Monoclonal antibody PH-30 raised against 
the fertilinp subunit blocks sperm-egg fusion [l]. CIonse- 
quently, when the sperm reaches the plasma membrane, 
fertilin is believed to bind to an egg plasma membrane 
receptor triggering fusion 14-61. 
FertilinP is present in all mammalian species screened to 
date, including humans. The same is true for fertilina 
except in humans and gorillas. In humans and gorillas, 
fertilina is a pseudogene that does not encode for a full- 
length protein [7,8]. The domain structures of fertilina 
and p have been predicted from their primary amino-acid 
sequences [Y]. Since the discovery of fertilin, a large 
family of cellular f&tin homologs containing both met- 
alloprotease and disintegrin domains has been identified 
and designated ADAM (a disintegrin and metallopro- 
teina>,e) [lo] or MDC (metalloprotease/disintegrin/cys- 
teine-.rich protein) [ll]. The mature forms of fertilina 
and fertilinp contain a disintegrin domain. a cysteine-rich 
region and an EGF-like repeat, in addition to a trans- 
membrane region and a short cytoplasmic rail; the metallo- 
protease domains have been proteolytically cleaved. Both 
recombinant extracellular fertilina and fertilinp bind to 
the microvillar region of zona-free eggs, where sperm pref- 
erentlally bind, and inhibit sperm binding [12-141. In 
addinon, fertilina contains a putative fusion peptide. 
Although fertilina is not expressed in humans or gorillas, 
other ADAM proteins could substitute as a partner for 
fertilin~, for example ADAM20 or ADL4M21 [lS]. In addi- 
tion, -ecent studies with fer:rtilit$ knockout mice suggest 
that 1 he role of fertilina might be different than origi- 
nally hypothesized, and further experiments are required 
to de:ermine what that role is [16]. Many of the ADAMS 
identified to date are present in mammalian male repro- 
ducrirre tissue, although new ADAMS have been found 
in Xuzopus testis [ 171. ADAMS are also present in somatic 
tissue. ‘They have diverse roles ranging from myoblast 
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Figure 1 
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2 MOUSY (ferriline) I101 CKLKRKGEVCRLAQDECDVTEYCNGTSEVC 
2 Monkey [681 CLPMSQERVCRPSFDECDLPEYCNGTSASC 
2 Guinea pig [91 CEFKTKGEVCREST~ECDLPEYCNGSSGAC 
2 Human [69] CLFMSKERMCRPSFEECDLPEYCNGSSASC 
2 cow [21 CAFIPKGHICRGSTDECDLHEYCNGSSAAC 
2 Rat [701 CNLKAKGELCRPANQECDVTEYCNGTSEVC 
2 Rabbit [711 CTFKERGQSCRPPVGECDLF~Y~~GTSALC 
3 Mouse (cyritestin) [721 CTlAERGRLCRKSKDQCDFPEFCNGETEGC 
4 Mouse [lOI CKPAPTGTICRDKNGICDLPEYCSGASEHC 
5 Mouse (tM!JC II) [lOI CTVKMNDWCRKSVDECDLLEYCNSKDPYC 
6 Rat (tMDC IV) [731 CTYSPSGTLCRPIQNICDLPEYCSGNNIFC 
9 Mouse (MDC 91 [741 CQFLPGGSMCRGKTSECDVPEYCNGSSQFC 
20 Human 1151 CKFLPSGTLCRQQVGECDLPEW‘~GTSHQC 
21 Human Cl51 CLPMPSGELCRQEVNECDLPEWCNGTSHQC 
18 Rat (tMDCIL1) [73] CELSAAGTPCRIL4VDPECDFTEYCNGTSSD; 
14 C. elegans (AMD-1) [75] CELRKAGDTCRSSKSPCDVAEQCDGKSGDC 
16 I(. laevis (xMDC16) 1171 CKLLPKGTLCRMPKTECDLAEYCDGASNHC 
Sequences of the binding-loop regions of representative disintegrins. 
For the sake of brevity, only a single sequence from each of the SVMP 
sub-families and nonmammalian ADAM sequences are shown. Also, 
only mammalian ADAM sequences expressed in testis are shown. They 
are listed in order of assigned ADAM number with any alternative 
names in parentheses The binding loops are blue. The consensus 
sequences are yellow (SVMP P-II), red (SVMP P-III), and magenta 
(SVMP P-IV and ADAM). Conserved cysteines are green. The relevant 
references are indicated. 
fusion in mammals [18] to nervous system development 
in Drosophila [ lY]. 
Prior to the discovery of fertilin. disintegrin domains were 
only known to occur as soluble snake toxins in snake 
venoms [20-221. These toxins are antagonists of platelet 
aggregation and bind to integrin receptors, hence their 
name. There are three classes of toxin that contain disinte- 
grin domains, SVMP-II, SVhlP-III and SVMP-IV [20]. All 
classes of disintegrin domains are rich in cysteine, and the 
positions of the cysteines are conserved. The tertiary struc- 
ture of the SVMP-II disintegrins has also been determined 
[23-2.51. The cysteines form a rigid disulfide-linked struc- 
ture that serves as a framework for presenting a Y-10 amino- 
acid loop that binds to the integrin receptor. ‘I’he consen- 
sus binding sequence of the SVMP-II disintegrins, Arg- 
Gly-Asp (RGD), is presented at the tip of this poorly struc- 
tured hairpin loop. SVMP-II disintegrins and small pep- 
tides containing the RGD sequence are antagonists of 
c$,,& and cQ%, integrins, present on platelets and stromal 
cells, respectively, that bind fibrinogen, Comparison of the 
putative binding loop of the disintegrin domain of fertilinp 
from different species highlights a consensus (D/E)ECD 
sequence (hereafter referred to as DECD), rather than RGD 
(Figure 1). There is no consensus sequence in the analo- 
gous region of fertilina. FertilinP is therefore more similar 
to the SVMP-IV class of disintegrins, for which the specific 
integrin target is not known. Moreover, fertilin is an inte- 
gral membrane protein, and the SVMPs are not. 
Considered together, these similarities and differences 
between fertilinp and the SVMPs suggested that fertilinp 
might be a cell-adhesion molecule that binds to an integrin 
receptor on the egg plasma membrane via its disintegrin 
domain; fusion might then occur via a second protein- 
protein Interaction [6], or simply as a result of adhesion [26]. 
In fact, the presence of integrins on the egg plasma mem- 
brane is well documented [27-311. Furthermore, the analogy 
between RGD disintegrins and DECD disintegrins appears 
to be correct; small peptides containing part of the consen- 
sus DECD sequence of fertilinp from the putative disinte- 
grin-binding loop inhibit sperm-egg fusion and/or binding 
in mice and guinea pigs [3,27,32-341. 
In elegant experiments, Almeida rtn/. (271 have shown that 
sperm will bind to somatic cells that express both or, and 
pi integrins. This bindrng is inhibited by DECD pep- 
tides and anti-a, monoclonal antibody (mAb). Further- 
more, Evans et al. [ 12,13] have developed an extraordinar- 
ily sensitive method for measuring binding of recombinant 
fertilin to single eggs. Binding of recombinant fertilinp to 
mouse eggs is reduced by peptides containing the DEC 
part of the DECD consensus sequence [12], suggesting 
that the DECD sequence is in the binding loop of fertilinB. 
Furthernore, recombinant fertilinp with the disintegrin 
domain deleted does not inhibit sperm-egg binding [14]. 
Binding of recombinant fertilinp is reduced by anti-p, poly- 
clonat antibody. Binding of recombinant fertilinb to mouse 
eggs is not reduced by anti-a,, mAb, however. There is 
agreement therefore that sperm fertitina binds to a pi inte- 
grin on the egg surface. The identity of the partner a 
subunit has not been clearly established. In addition, the 
above-described experiments do not eliminate the possi- 
bility that other extracellular proteins, present both in 
somatic cells and eggs, are required for binding of fertilinp 
and sperm to the egg surface integrin. 
In our work, we have investigated the cellular target of 
these DECD peptides, and thus of fertilinp. We wanted to 
establish if there is a direct binding interaction between 
sperm fertilin(3 and egg integrins, or if mediator proteins are 
required. [‘sing peptide inhibition, photoaffinity labeling 
and immunoprecipitation, we have shown that DECD 
peptides bind to egg c+$, integrin without mediation by 
other sperm proteins. The DECD peptides represent a new 
ligand motif for integrin’s that have a different specificity 
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than RGD peptides. These results suggest that fertilinp 
binds directly to the ah& integrin on the egg surface and 
this partnership mediates sperm-egg fusion. 
Results and discussion 
Design and synthesis of photoaffinity label 1 
A number of groups have synthesized peptides that cor- 
respond to part of the putative binding loop (Figure 1) of 
the disintegrin domain of fertilinp, as well as other ADA\,1 
proteins present on the sperm surface, for example, 
ADAM 5 and cyritestin (ADAM 3). and tested them as 
inhibitors of sperm-egg binding and fusion [3,27,32-341. 
Peptides containing the ECD sequence inhibit fusion by 
50% at 500 @I [33], as does a peptide with the sequence 
AQDEC [32]. Dimers of the ECD peptides or cyclic 
disulfides of CAQDEC do not inhibit fusion, nor does a 
cyclic peptide containing the sequence MD. A longer 
fertilinl) sequence CRLAQDEADVTEYC in which the 
cysteine residue of ECD is replaced with an alanine 
residue, results in 50% inhibition at 2.50 @I [27]. These 
experiments suggest that binding affinity is gained from 
residues adjoining the consensus sequence, and that the 
cysteine of ECD is not present in a disulfide. If  the 
DECL) sequence is presented in the wrong context, it 
does not bind to the egg receptor. This is borne out by 
the result that an ADAM 5 peptide, SVL)ECDI,L, does 
not inhibit binding or fusion [3]. It is not yet clear whether 
the variability of the first aspartate residue in the DECD 
sequence of fertilinp across different species is a result of 
receptor-specificity differences between species or because 
that residue is not as important for binding. Cyritestin 
has a DQCD sequence rather rhan a DECD sequence 
and the corresponding binding-loop peptide, SKDQCDFP, 
shows 50% inhibition at 70-80 @I [3]. The amino-acid 
sequences of the putative binding loops of fertilinp and 
cyritestin are significantly different, suggesting that they 
might have different binding partners on the egg surface. 
Thus, the minimal peptide required to mimic fertilinp 
and to inhibit sperm-egg fusion contains the DECD 
sequence with a reduced thiol. ‘I’wo flanking amino acids 
at the amino and carboxyl termini confer specificity. 
In order to determine the direct target of the fertilinp dis- 
integrin-binding loop, we synthesized the radioactive pho- 
toaffinity probe! 1, that contains 12 amino acids of the 
mouse binding l~oop (Figure 2). We extended the minimal 
DECD sequence by two additional amino acids from the 
fertilinp sequence on either side of the DECD to ensure 
specificity. Two additional amino acids from the fertilinp 
sequence were included at the amino terminus of AQD- 
ECDVT, to avoid steric interference at the receptor- 
binding site upon incorporation of the photoaffinity label, 
4-benzoyl-phenylalanine, at the amino terminus. RLAQD- 
ECDVT was extended by three amino acids at the car- 
boxy1 terminus to include the tyrosine residue present in 
the fertilinp sequence. This tyrosine residue served as a 
handle for introduction of an lrsI label. An alanine residue 
was substituted for the cysteine residue at the carboxyl 
terminus in fertilinp to simplify the synthesis. 
We chose 4-henzoyl-phenylalanine as our photoaffinity 
probe because of the ideal characteristics of the benzophe- 
none moiety [35-371. Benzophcnone is excited to its active 
ketyl diradical at 3.50-360 nm. This property allows the 
probe to be manipulated in ambient light and also mini- 
mizes photodamage of proteins. Furthermore, benzophe- 
none is more stable than other photoprobes such as azides 
or diazo esters. Excited henzophenones react preferen- 
tially with unreactive C-H bonds; buffer nucleophiles and 
solvent water do not interfere with labeling. Benzophe- 
none is a selective photoprobe primarily because hydrogen 
abstraction must be followed by combination of the ketyl 
and alkyl radicals formed to achieve labeling. The photo- 
probe must therefore have a sufficient residence time in 
the receptor, that is, high affinity, for labeling to occur. 
The peptide photoprobe was synthesized using standard 
solid-phase methods, with FMOC (N”-9-fluorenylmethy- 
loxycarbcmyl) a-amino protection [38,39]. The peptide was 
cleaved from the resin and deprotected to yield the reduced 
peptide 2 (Figure 2). The disulfide dimer of 2 was prepared 
by dimcthyl sulfoxide (DMSO)-catalyzed air oxidation to 
protect the thiol during the iodination reaction and could 
be stored for extended periods of time. The tyrosine 
residue in dimer 2 was iodinated using chloramine-T and 
Na’z”I to yield dimer 1, which was reduced to 1. purified 
using high performance liquid chromatography (HPLC) 
and used immediately for photoaffinity labeling experi- 
ments (Figure 2). Peptide .3, which contains the same amino 
acids as 1 except in a scrambled order, was synthesized and 
used in photoaffinity labeling experiments as a control. 
Inhibition of in vitro fertilization with DECD peptides 
Peptides 2-4 were tested in a mouse irz oitrtl fertilization 
assay (Table 1). Both the fertilization rate (number of eggs 
fertilized) and fertilization index (number of sperm fused 
per egg) 1341 were determined using zona-free eggs in the 
absence end the presence of the peptides. As expected, 2 
is a good inhibitor of sperrn-egg fusion. Lack of inhibition 
by the scrambled peptide 3 demonstrates that inhibition 
of fusion is not an artifact arising from addition of ben- 
zophenone to the peptide sequence. Inhibition by the 
linear peptide AC-ECDAY-NH2, 4, has been described 
previously [33]. This peptide is used as a positive control 
in the labeling experiments described below. A mimic of 
the fertilinp disintegrin domain containing a 4-benzoyl- 
phenylalanine, the DECD peptide 2. is therefore a good 
inhibitor of sperm-egg fusion in vitro. 
Photoaffinity labeling of the fertilinp receptor 
After the inhibitory potency of 2 was determined, a 
photoaffinity labeling experiment was performed using 
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Structure and synthesis of peptide 1. 
Peptides 1 and 3 were a 5:l mixture of mono- 
and di-iodinated tyrosine. Please see text for 
more details. 
the radioiodinated form of 1 and the scrambled peptide 3. 
Peptide 1 was incubated with zona-intact mouse eggs, 
and the eggs irradiated with near ultraviolet (UV) light to 
form a covalent bond between peptide and receptor. The 
Table 1 
inhibition of in vitro fertilization by peptides. 
Peptide Concentration o/o Inhibition FR’ % Inhibition Fit 
2* 90 uM 53* 10 53+10 
2* 125 pM§ 70f 14 72+ 14 
3 500 uM 9+9 11+9 
4x 500 uM 51 f17 51+17 
The results here represent the average + s.d. for 4-7 independent 
experiments and 60-l 50 eggs per peptide. *The percentage inhibition 
as measured by number of eggs fertilized (fertilization rate, FR) relative 
to a nonpeptide control. The percentage inhibition as measured by the 
number of sperm fused per egg (fertilization index, FI). +The fertilization 
index and rate for the no peptide control were 0.83 sperm/egg and 
72% eggs fertilized, respectively. §This concentration is the highest 
obtainable due to its solubility. #The sequence of control peptide 4 is 
AC-ECDAY-NH, [33). 
eggs were gently pelleted, washed to remove excess 
peptide. lysed with sodium dodecyl sulfate (SDS), boiled 
and analyzed by gel electrophoresis. In a parallel experi- 
ment, 1 and excess 4 were incubated with zona-intact 
eggs, iradiated, lysed and analyzed. The same experi- 
ment was performed with peptide 3. 
One poiypeptide with an apparent molecular weight (Ml,) 
of 115,000 (in its reduced and denatured state) is labeled 
by 1 (Figure 3a); the nonreduced M, of this polypeptide 
is 132,000 (Figure 3b). A second, much less intense band 
of M, = 95,000 (reduced or nonreduced) is also observed. 
In the presence of a 125fold excess of nonradioactive 
reversible inhibitor 4, no spccitic labeling of the protein is 
observed (Figure 3~). Instead, a low-level nonspecific label- 
ing of extracellular egg proteins occurs. Thus, the labeling 
by 1 is competitive with reversible inhibitors, that is, the 
incorporation of 4-benzoyl-phenylalanine and iodotyrosine 
into the DECD peptide does not alter its binding speci- 
ficity. Furthermore. no labeling by the scrambled peptide 3 
was observed (Figure 3rl). The presence of the 4-benzoyl- 
phenylalanine and iodotyrosine is not causing labeling 
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Figure 3 
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Autoradiograms of photoaffinity-labeled egg proteins. Approximately 
800 zonaintact eggs were used per lane. Bars indicate where 
prestained molecular weight standards appeared on the gel. Each gel 
is from a single representative experiment; the labeling reactions were 
performed three or more times. (a) A 6% reducing SDS-PAGE gel of 
the labeling reaction performed with 1 (4 yM). (b) A 6% nonreducing 
SDS-PAGE gel of the labeling reaction performed with 1 (4 PM). (c) A 
6% reducing SDS-PAGE gel of the labeling reaction performed with 1 
(4 PM) + 4 (500 PM). (d) A 6% reducing SDS-PAGE gel of the 
labeling reaction performed with 3 (4 PM). 
artifacts. Sperm were not photoaffinity labeled by 1 (data 
not shown). These experiments demonstrate that DECD 
peptides inhibit fertilization by binding specifically to a 
single extracellular protein on the egg. 
Identification of the fertilinp receptor 
We performed! immunoprecipitations with detergent 
soluble extracts of zona-intact mouse eggs labeled with 1. 
We tested for integrins previously reported to be present 
in mouse eggs: cl”, &, IX,, p, and & [27-311. Separate 
aliquots of labeled egg extract were incubated with each 
anti-integrin antibody, and antibody-integrin complexes 
were precipitated with protein G sepharose. The immuno- 
precipitation pellets and supernatants were analyzed by 
gel electrophoresis (Figure 4a.b). The quantity of labeled 
polypeptide in the pellets and supernatants of each 
immunoprecipitation experiment was determined by phos- 
phorimaging (Figure 4c,d). Both anti-a, and anti-p, mono- 
clonal, as well as polyclonal anti-FNR (I@~), antibodies 
precipitate the labeled protein. Anti-a,, anti-a,, anti-& 
monoclonal antibodies do not precipitate the labeled 
protein. The small amount of polypeptide seen in these 
lanes (-IO% of the total labeled polypeptide) is less than is 
observed in the rabbit IgG serum control lane, and is 
attributed to nonspecific binding to either the antibody or 
the protein G sepharose. After two precipitations with either 
the anti-a, or the anti-p, antibodies, the polypeptide was 
completely cleared from the supernatant. The complete 
precipitation indicated that the band on the gel was not 
due to labeling of two different polypeptides of the same 
electrophoretic mobility. 
The ah and p, integrins have very different changes in 
mobility between reducing and nonreducing gels. Murine 
a6 is comprised of a heavy chain (M, = llS,OOO-120,000) 
and a light chain that are separated upon reduction, the 
nonreduced M, is 130,000-135,000 [40,41]. In contrast, 
the M, of murine p, increases upon reduction from 
M, = 115,000-120,000 (nonreduced) to 130,000-135,000 
(reduced); presumably reduction of intramolecular disul- 
fides decreases its electrophoretic mobility [40,41]. The 
decrease in M, of the l-labeled polypeptide from 130,000 
to 115,000 upon reduction identifies the l-labeled poly- 
peptide as the heavy chain of ah (Figure .3a,b). The iden- 
tity of the M, = 95,000 band is not known, it is probably a 
proteolytic degradation product of o+, because the amount 
present increased with sample handling despite the pres- 
ence of protease inhibitors. The p, polypeptide is not 
labeled with 1, but is clearly complexed with the labeled 
ah, because anti-p, monoclonal antibodies immunoprecip- 
itate the labeled 01,. 
Both the anti-a, and anti-S1 monoclonal antibodies used 
are specific for their respective integrin subunits [40,42]. 
The quantitative precipitation of the polypeptide labeled 
with 1 by these antibodies eliminates the possibility that 
other integrin subunits o’r other proteins not screened in 
this experiment are labeled (Figure 4). Furthermore, the 
molecular weights of intlegrin a chains are not identical. 
The presence of a single band on the autoradiogram 
(Figure 3a) strongly suggests that only one type of a 
chain is labeled, ~1~. Using the specific activity of our 
photoprobe (2500 Ci/mmol), the amount of radioactivity 
in the immunoprecipitation pellets, and an estimated 
labeling efficiency of 20’% (average value for benzophe- 
none [37]), we can calculate the concentration of ah& on 
the egg surface. There is approximately 50 attomol of 
fertilinp receptor on the surface of each egg. 
The remarkable specificity of the peptide 1 for 01$~, and 
the fact that an AQDEC peptide inhibits binding of 
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Figure 4 
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Autoradiograms and quantitation of immunoprecipitation experiments. percentage of labeled polypeptide in the first pellet (P, dark gray bar), 
(a) Autoradiograms of a representative immunoprecipitation of labeled second pellet (P, light gray bar), and second supernatant (S, light gray 
polypeptide. Photoaffinitylabeled proteins were immunoprecipitated bar), was plotted. Note, half of each supernatant was loaded on the gel 
with anti-integrin antibodies. Each pellet (P) and half of each supernatant in the first immunoprecipitation, and half was used for the second 
(S) was analyzed on a 6% reducing SDS-PAGE gel. Approximately addition of antibody. The raw data were corrected for this split before 
100 zonaintact eggs were used per lane. Bars indicate where calculating the percentages. (d) Summary of immunoprecipitation 
prestained molecular weight standards appeared on the gel. (b) The experiments. The percentage of labeled polypeptide in the pellet (P) is 
remaining half of each supernatant was immunoprecipitated with the the sum of the first and second immunoprecipitation pellets (corrected 
same anti-integrin antibody, and the pellet and supernatant loaded onto for nonspeoific precipitation as determined by the IgG control) divided 
a 6% reducing SDS-PAGE gel. The immunoprecipitations were by the total amount of labeled polypeptide (first pellet, second pellet and 
performed at least five times with each antibody. (c) The experiment second supernatant) for a single antibody. The error bars are * sd. for 
shown in panels (a) and (b) was quantified. For each antibody, the two to three independent labelirlg experiments. 
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recombinant fertilinp to eggs [12], imply that ah& is the 
receptor for fertilin. Furthermore, anti-or, mAb GoH3 
stains eggs in the microvillar region [27,43]. This location 
is consistent w:lth the role of a&3, as a sperm fertilinp 
receptor that mediates sperm-egg fusion. 
cx.$, lntegrin mediates sperm-egg binding 
Prior studies have addressed the role of various integrins in 
fertilization. Sperm will bind to cultured somatic cells if 
they express cxh and pt. In cells missing either a, or fi,, 
binding of sperm is reduced S-lo-fold and the high level of 
binding is restored upon transfection of the missing integrin 
[27]. This binding is inhibited by the addition of DECD 
peptides [27]. These experiments therefore suggested that 
both ah and p, mediate sperm binding. but did not provide 
direct evfidence that sperm were binding to the a&3, 
complex. These experiments did not eliminate the possibil- 
ity that additional receptors or ligand proteins are required 
for binding of fertilinp - that is, they did not establish that 
direct binding of fertilinp to the a$, integrin occurs [27]. 
Our photoaffinity-labeling experiments demonstrate that 
the disintegrin DECD loop of fertilinp binds directly to 
IX,& without an intermediate ligand protein. Furthermore, 
sperm coreceptors are not required for binding. 
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Earlier experiments by others to inhibit sperm binding or 
fusion with antibodies suggested that a p1 integrin interacts 
with fertilinp [12,27]. Experiments with anti-a, mono- 
clonal antibodies have yielded conflicting results. The iden- 
tity of a$, as a laminin receptor was established using a 
function-blocking mAb GoH3 144,451. This same mAb has 
been used to characterize sperm-egg interactions. Almeida 
et u/. [27] reported that anti-a, mAb GoH3 inhibits sperm-- 
egg binding to zona-free mouse eggs in a concentration- 
dependent manner, although it does not inhibit fusion. 
Two other groups, however, were unable to inhibit fertil- 
ization or sperm-egg binding with GoH3, the same anti-a, 
mAb [ 12,301. Evans et UL [ 121 have shown that these differ- 
ences arise from the different methods (acid versus chy- 
motrypsin treatment) used to remove the zona pellucida 
from the eggs. Furthermore, they demonstrated that eggs 
with increased amounts of GoH3 epitope (i.e., chymo- 
trypsin-treated) bind half as many sperm and 30% less 
recombinant f&-tilinp than eggs with Z-3-foid less GoH3 
epitope (i.e., acid-treated). These data presented an appar- 
ent paradox in that eggs with less GoH3 epitope (i.e., a,) 
bound more sperm and recombinant fertilinp than eggs 
with more epitope. They also showed that binding of 
recombinant fertilinp was not blocked by GoH3 regardless 
of zona-removal method. 
In our labeling experiments, we do not remove the zona 
pellucida - that is, the eggs are not treated with acid or 
chymotrypsin before labeling. All the extracellular egg 
proteins are unmodified and intact. IJnder these condi- 
tions, the GoH.3 mAb immunoprecipitates a$, that is 
covalently labeled with a 14 amino-acid DECD peptide 
(Figure 4). Thus, binding a small fertilinp mimic does not 
block the GoH3 epitope. 011r experiments suggest that 
the laminin- and DECD-binding sites are not identical. 
Perhaps chymotrypsin treatment alters the conformation 
of ah& sufficiently such that sperm binding becomes 
GoH3 sensitive. The conformational changes of integrins 
are well documented and can be assayed using mono- 
clonal antibodies specific for exposed and unexposed epi- 
topes [46]. Reduced levels of epitope do not necessarily 
correlate with reduced levels of antigenic protein. Com- 
plete resolution of these differences requires epitope 
mapping of the monoclonal antibodies. and mapping of 
the DECD- and laminin-binding site(s) and chymotrypsin 
cleavage site(s) in a,&. 
Previously, C& was believed to bind exclusively to the 
E8 fragment of A-chain laminin (4.5,47,48]. Our results 
provide direct evidence that ligands other than laminin 
bind to CX,~,. c@, therefore plays a role in mediating 
cellxell interactions, in addition to its previously deter- 
mined function in cell-matrix attachment. Eggs do not 
express iaminin; it is expressed later during embryogene- 
sis 1291. Laminin is, however, present on the acrosomal 
surface of sperm [49,50]. a$, is also present during 
embryl)genesis [29]. The ligand specificity of integrins is 
modulated by a variety of agents and events [Sl]. These 
diverse roles might be modulated by variable splicing 
[.52-541. Splicing in the extracellular domain of c@, regu- 
lates iti affinity for laminin [55]. Although, splicing in the 
same position of the extracellular ligand-binding domain 
of a$ does not regulate its affinity for laminin [.56], it 
could regulate its affinity for fertihnp. 
Althou,;h we have provided strong evidence that a fer- 
tilir$-+,PI interaction mediates sperm-egg fusion, the 
steps after binding remain undefined. It has been pro- 
posed that fertilina contains an amphipathic fusion peptide, 
similar to viral fusion peptides, and triggers fusion after 
binding through fertilinp 191. Recent experiments have 
shown that the fertilinfl peptide. which is cationic, has a 
P-sheet structure and only fuses vesicles containing anionic 
lipids [57]. It therefore has a different fusion mechanism 
than th: fusion pcptide of HIV2 gp41, a known P-sheet- 
fusion peptide 1.581. Fertilina is homologous to meltrina. 
another ADAM protein1 implicated in myoblast fusion, 
offering further indirect evidence that fertilina is a fusion 
protein [18]. Sperm bind to somatic cells expressing a,,&. 
but do 7ot fuse [27], however. suggesting that other egg- 
specific proteins are required for fusion. l‘his is the case in 
other types of cell fusion, for example, the recent discov- 
ery that chemokine receptors are required as HIV-1 core- 
ceptors in viral fusion [59]. Tn addition, there are at lcast 
ten different ADAM family members [ 11,60] expressed in 
mouse testis, any number of which could be required for 
fusion. Other nonADAM proteins could a1so be involved. 
Recent (experiments suggest that the sperm proteins cyri- 
testin [3] and fertilina [.I31 also bind to receptors on the 
egg plasma membrane. Furthermore, fertili&- sperm 
from fertilinp knockout mice show reduced levels of fer- 
tilina present in the sperm. Although fertilinp-I- sperm 
binding to the egg is redllced eightfold compared to wild- 
type sperm in d-o, sperm-egg fusion is only reduced 50% 
[16]. l’his observation suggests that multiple adhesion 
interactions occur before and during fusion. IJnraveling 
this complexity is necessary for a complete understanding 
of the sperm-egg fusion process. 
Significance 
In mammals, the sperm protein fertilinb is involved in 
adhesion of a sperm to the egg plasma membrane. Fertil- 
inp is a member of the widely distributed family of extra- 
cellular membrane-bound proteins termed ADAMS (a 
disintegrin and metalloproteinase). We have obtained very 
strong elridence for the identity of the fertilinp receptor 
using a receptor-specific photoaffinity label and immuno- 
recognition. The photoaffinity label used was a peptide 
corresponding to the binding loop of the disintegrin 
domain of fertilinp that inhibits fertilization in vitro. We 
conclude that the photoaffinity peptide, and therefore, 
fertilinj3. binds directly and with high specificity to a& 
8 Chemistry & Biology 1999, Vol 6 No 1 
integrin without mediating proteins. This binding event 
moderates fusion. Localization of the c@, integrin on 
the microvillar surface of eggs is consistent with its par- 
ticipation in sperm-egg fusion. Our results indicate that 
ADAM disintegrins and integrins mediate cell-cell 
interactions. The DECD disintegrin-binding loop repre- 
sents a new &and motif for integrins. How widely this 
type of ligand-receptor pair is utilized remains to be 
determined. Potentially, ADAM-integrin interactions 
could modulate functions as diverse as myoblast fusion 
[ 181 and neurogenesis [ 191. 
Further work will be required to determine whether 
fertilir$ binding to C& is the only receptor-ligand 
interaction required for sperm-egg fusion. The suc- 
cesses in developing Arg-Gly-Asp (RGD) antagonists 
specific for ar& [611 or a& [621 suggest that CL&, is 
an important target for rational and combinatorial drug 
design (using the DECD motif) to develop new methods 
of contraception. 
Materials and methods 
General 
Amino acids were purchased from Advanced Chemtech (Louisville, 
KY), except 4-benzoyl-phenylalanine (Bpa), which was purchased 
from Bachem (Philadelphia, PA). Peptide synthesis resin and O-(7., 
azabenzotriazol-1 -yl)-1 ,1,3,3,-tetramethyluronium hexafluorophosphate 
(HATU) were purchased from Perseptive Biosystems (Framingham, 
MA). [i*51]-Sodium iodide was purchased from Amersham Life Science 
(Arlington Heights, IL). Solvents were from Fisher Scientific, Inc 
(Springfield, NJ). Other reagents were purchased from Sigma-Aldrich 
Co. (Milwaukee, WI). MALDI-TOF mass spectrometry was carried out 
using a Bruker Protein TOF instrument at the CASM, SUNY at Stony 
Brook. The matri.r used was a-cyano-4-hydroxycinnamic acid. Mass 
calibrations were performed using internal standards with appropriate 
molecular weights. The HRFAB mass spectra were acquired on a 
70-SE-4F mass spectrometer in the Mass Spectrometry Laboratory, 
School of Chemical Sciences, University of Illinois. A Molecular 
Dynamics 445 Phosphorlmager and lmagequant software were used 
for analysis of 1251-protein gels. 
Synthesis of peptide 1 
Peptides were synthesized on a Rainin PS3 synthesizer using FMOC 
a-amino protection, t-butyl, trityl and 2,2,5,7,8-pentamethylchroman-6- 
sulfonyl (PMC) sidechain protection, [5-(4-aminomethyl)-l-(3,5-dimeth- 
oxyphenoxy)-valeratel-polyethylene glycol-polystyrene (PAL-PEG) resin 
and HATU activation to yield the carboxy-terminal amide. Amino acids 
and activator were used in fourfold molar excess with dimethylformamide 
as solvent. All amino acids were of the L-configuration. The peptides 
were purified by Cl 8 reversed-phase HPLC using a linear gradient from 
5% to 95% 0.1% TFA/CH,CN in 0.1% TFA/H,O. The molecular mass 
of the peptides was confirmed by mass spectrometry. 
The UV spectrum of 2 had a h,,= 262 nm as expected for a peptide 
containing 4-benzoyl-phenylalanine. The pure peptide was analyzed 
by HRFAB mass spectrometty (MH+ calc’d: 1762.7754; found: 
1762.7734). Pepti,de 2 was dimerized in 20% DMSO in air at pH 8, and 
purified again by Cl 8 HPLC. The dimer (2.8 nmol) was radioiodinated 
with Nal 251 (2.5 Ci/pmol, 2 mCi) and N-chloro-p-toluenesulfonamide, 
sodium salt (chloramine-T) (1 nmol) in 50 mM sodium phosphate, pH 6.5 
buffer for 1 min. The reaction was quenched with sodium thiosulfate, 
and then reduced with dithiothreitol (10 mM) for 2 h. The iodinated 
peptide (2.5 Ci/pmol) was purified by HPLC as described above. The 
identity of the radioiodinated sample was confirmed by coinjection with 
authentic; cold iodinated peptide that had been prepared in an analo- 
gous fashion and analyzed by mass spectrometry. HPLC and mass 
spectrometry analysis showed that the peptide was a 5:l mixture of 
mono- and di-iodinated tyrosine. The mixture was used for photoaffinity 
labeling (experiments. Peptide 3 was prepared in an analogous fashion. 
Antibodies 
Antibodies were obtained from the following sources: polyclonal rabbit 
FNR antIserum (versus human whole FNR), Gibco-BRL Life Technolo- 
gies, Inc. (Gaithersburg, MO); rat mAb 5HlO-27 (versus mouse CL~), 
hamster mAb H9.2BB (versus mouse a,,), rat mAb GoH3 (versus 
human 0,s)’ rat mAb KM16 (versus mouse &), hamster mAb 2CS.G2 
(versus rlouse ps), Pharmingen Incorporated (San Diego, CA). 
In vitro fertilization assay 
Eggs and sperm were isolated from ICR (Laconic Farms) or CD-l 
(Charles River) mice as described in Yuan et a/. [31. Zona pellucida 
were removed by treatment ,with acid Tyrode’s solution [63] for 30 s. 
Zona-free eggs were loaded with Hoechst 33342 (1 pg/ml) for 30 min 
[64] and washed through six 40 1.11 drops of Ml 6 medium (0.5% BSA) 
and recovered at 37”C, 5% CO, for 1 h. 
Eggs (~CI-30/40 ~1) were incubated with peptide in Ml 6 medium (3% 
BSA) for 45 min and then sperm were added (1 .O-2.0 x 1 04/ml). After 
45 min, the eggs were washed in Ml6 medium (3% BSA) and 
mounted onto microscope slides. Fusion was scored by fluorescent 
labeling of sperm nuclei by Hoechst 33342 present in the preloaded 
eggs. Four to seven experiments per peptide were performed and a 
total of 613-150 eggs per peptide were used. 
Photoafi’inity labeling 
Zona-intact eggs were prepared as described 131 to remove cumulus 
cells. They (-800 eggs) were photoaffinity labeled with 1 (4 FM, 
2.5 Ci/pmol) for 15 min with a near UV lamp (14 watts, 6 cm, 
&,, = 350 nm), 4°C in Ml 6 medium (1 o/, polyvinylpyrrolidone (PVP), 
100 ~1). n parallel experiments, eggs (-800) were labeled with 1 
(4 PM) ard 4 (500 PM), or 3 (4 PM, 2.5 Ci/pmol). The eggs were gently 
centrifuged at 2 000 x g and washed with Ml 6 medium (la/, PVP) six 
times to remove unreacted peptide. The eggs were resuspended in 
lysis buffer (2% SDS, 40 PI), boiled for 5-10 min, centrifuged to 
remove insoluble zona and loaded onto an SDS-PAGE gel. Lysis 
buffer for reducing gels contained 10% /3-mercaptoethanol. The gel 
was driecl, and exposed to X-ray film at -80°C for 5-24 h using two 
intensifying screens or exposed to a phosphorimaging plate for 24 h. 
Sperm were treated in an analogous fashion. 
Immunoprecipitations 
Zona-intact eggs (- 1000) were photoaffinity labeled with 1 (4 PM) and 
washed as described above. The eggs were resuspended in TBS (800 pl) 
containing 0.5% triton X-100, 1 mM CaCI,, 1 mM MgCI,, 1 kg/ml leu- 
peptin, 1 Irg/ml pepstatin and 1 mM phenylmethylsulfonyl fluoride, incu- 
bated at 4°C for 20 min, centrifuged to remove insoluble zona and the 
supernata7t divided into 8 aliquots. Each aliquot had between 8000 and 
10,000 dpm of lz51-1 -labeled protein. The appropriate primary antibody 
(5-l 0 Kg for monoclonals and 0.25-0.5 pl serum for polyclonals) was 
added to each aliquot and incubated at 4’C for 4-18 h. Protein G 
sepharose (50 pl slurry) was added and the mixture incubated at 4°C for 
an additional 2 h. The mixtures were centrifuged at 10,000 xg for 
10 min, and the supernatants transferred to fresh tubes. The pellets were 
washed two times with incubation buffer (150 ~1 each) and resuspended 
in gel loading buffer (2% SDS, 1 Oo/, P-mercaptoethanol) buffer (40 ~1). 
Half of eac:h supernatant was concentrated to 20 pl in Micron-30 micro- 
concentralors (Amicon, Danvers, MA) and mixed with 2x gel loading 
buffer. Boih the concentrated supernatant and resuspended pellet were 
loaded onio a 6% SDS-PAGE gel. The gel was dried, and exposed to a 
phosphorimaging plate for 24 -100 h. The remaining half of each super- 
natant was treated a second time with the same anti-integrin antibody 
and processed as described above. The immunoprecipitations were per- 
formed at least five times with each antibody. 
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